Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.68 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.68 |
| ▸ | PRKD2 | Q9BZL6 | 2/20 | 0.68 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 4/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4512433 | 1.00 | PRKD3 (0.68) | PRKD3PRKD1PRKD2HRH4MAP4K4 | |
| SCHEMBL4512429 | 1.00 | PRKD3 (0.68) | PRKD3PRKD1PRKD2HRH4MAP4K4 | |
| SCHEMBL8229748 | 0.90 | PRKD3 (0.70) | PRKD3PRKD1PRKD2CLK4SMN1; SMN2 | |
| SCHEMBL4523068 | 0.90 | PRKD3 (0.72) | PRKD3PRKD1PRKD2CLK4SMN1; SMN2 | |
| SCHEMBL4523066 | 0.90 | PRKD3 (0.72) | PRKD3PRKD1PRKD2CLK4SMN1; SMN2 | |
| SCHEMBL4523059 | 0.90 | PRKD3 (0.72) | PRKD3PRKD1PRKD2CLK4SMN1; SMN2 | |
| SCHEMBL4518268 | 0.89 | PRKD3 (0.69) | PRKD3PRKD1PRKD2DYRK1ACLK4 | |
| SCHEMBL4518283 | 0.89 | PRKD3 (0.69) | PRKD3PRKD1PRKD2DYRK1ACLK4 | |
| SCHEMBL4518280 | 0.89 | PRKD3 (0.69) | PRKD3PRKD1PRKD2DYRK1ACLK4 | |
| SCHEMBL3918583 | 0.89 | PRKD3 (0.64) | PRKD3PRKD1PRKD2DYRK1ACLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247519-A1 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247519-A1 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE | PKD2, PKD1, AADAT | PRKD3 9/4885PRKD1 49/4885PRKD2 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.